{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:48:32Z","timestamp":1791035312890,"version":"4.1.0"},"reference-count":63,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Oropharyngeal squamous cell carcinoma (OPSCC) comprises cancers of the tonsils, tongue base, soft palate, and uvula. The staging of oropharyngeal cancers varies depending upon the presence or absence of human papillomavirus (HPV)-directed pathogenesis. The incidence of HPV-associated oropharyngeal cancer (HPV + OPSCC) is expected to continue to rise over the coming decades. PET\/CT is a useful modality for the diagnosis, staging, and follow up of patients with oropharyngeal cancers undergoing treatment and surveillance.<\/jats:p>","DOI":"10.3390\/cancers15092651","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:03:31Z","timestamp":1683511411000},"page":"2651","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Role of PET\/CT in Oropharyngeal Cancers"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8481-3978","authenticated-orcid":false,"given":"Emily W.","family":"Avery","sequence":"first","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saral","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Yale University School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-2209","authenticated-orcid":false,"given":"Amit","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"ref_1","unstructured":"Society, A.C. (2022). Cancer Facts & Figures 2022, American Cancer Society."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.sult.2008.05.006","article-title":"Combined positron emission tomography-computed tomography: The historical perspective","volume":"29","author":"Townsend","year":"2008","journal-title":"Semin. Ultrasound CT MR"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00003072-200011000-00010","article-title":"Image analysis in patients with cancer studied with a combined PET and CT scanner","volume":"25","author":"Charron","year":"2000","journal-title":"Clin. Nucl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1095-0397(01)00055-3","article-title":"Combined PET\/CT Imaging in Oncology. Impact on Patient Management","volume":"3","author":"Kluetz","year":"2000","journal-title":"Clin. Positron. Imaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00003072-200011000-00005","article-title":"Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography","volume":"25","author":"Meltzer","year":"2000","journal-title":"Clin. Nucl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaoto.2021.3567","article-title":"Oropharyngeal Cancer Incidence and Mortality Trends in All 50 States in the US, 2001\u20132017","volume":"148","author":"Damgacioglu","year":"2022","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/lary.28059","article-title":"Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma","volume":"130","author":"Bauer","year":"2020","journal-title":"Laryngoscope"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): A multicentre cohort study","volume":"17","author":"Huang","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/cncr.32652","article-title":"Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status","volume":"126","author":"Fullerton","year":"2020","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nic.2012.08.005","article-title":"Pitfalls in the staging of cancer of the oropharyngeal squamous cell carcinoma","volume":"23","author":"Corey","year":"2013","journal-title":"Neuroimaging Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.suronc.2013.06.002","article-title":"18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: A meta-analysis","volume":"22","author":"Zhu","year":"2013","journal-title":"Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s00106-017-0391-3","article-title":"The 8th edition of the AJCC Cancer Staging Manual: Updates in otorhinolaryngology, head and neck surgery","volume":"65","author":"Doescher","year":"2017","journal-title":"HNO"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.207.1.9530307","article-title":"Comparison of CT and MR imaging in staging of neck metastases","volume":"207","author":"Curtin","year":"1998","journal-title":"Radiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaoncol.2021.6416","article-title":"Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy","volume":"8","author":"Tsai","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2014.07.042","article-title":"PET\/CT imaging-guided dose painting in radiation therapy","volume":"355","author":"Shi","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Heukelom, J., Hamming, O., Bartelink, H., Hoebers, F., Giralt, J., Herlestam, T., Verheij, M., van den Brekel, M., Vogel, W., and Slevin, N. (2013). Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-84"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/hed.24892","article-title":"Long-term outcome of (18) F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study","volume":"39","author":"Berwouts","year":"2017","journal-title":"Head Neck"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2015.05.012","article-title":"Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer","volume":"93","author":"Ng","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1017\/S002221511600058X","article-title":"Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Paleri","year":"2016","journal-title":"J. Laryngol. Otol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1200\/JCO.18.01182","article-title":"Multicenter Trial of [(18)F] fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685","volume":"37","author":"Lowe","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102662","DOI":"10.1016\/j.amjoto.2020.102662","article-title":"Choice of imaging modality for pre-treatment staging of head and neck cancer impacts TNM staging","volume":"41","author":"Mur","year":"2020","journal-title":"Am. J. Otolaryngol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1158\/1078-0432.CCR-22-0562","article-title":"Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma","volume":"28","author":"Berger","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hed.20080","article-title":"Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer","volume":"26","author":"McCollum","year":"2004","journal-title":"Head Neck"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00259-011-1893-y","article-title":"Diagnostic performance of post-treatment FDG PET or FDG PET\/CT imaging in head and neck cancer: A systematic review and meta-analysis","volume":"38","author":"Gupta","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00259-015-3051-4","article-title":"Prognostic significance of standardized uptake value and metabolic tumour volume on (1)(8)F-FDG PET\/CT in oropharyngeal squamous cell carcinoma","volume":"42","author":"Kim","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hed.23920","article-title":"Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma","volume":"38","author":"Schouten","year":"2016","journal-title":"Head Neck"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/RLU.0000000000000691","article-title":"Do 18F-FDG PET\/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?","volume":"40","author":"Kendi","year":"2015","journal-title":"Clin. Nucl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100305","DOI":"10.1016\/j.ctarc.2021.100305","article-title":"PET-CT scan-based maximum standardized uptake value as a prognostic predictor in oropharynx squamous cell cancer","volume":"26","author":"Patel","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2967\/jnumed.111.093443","article-title":"Impact of the definition of peak standardized uptake value on quantification of treatment response","volume":"53","author":"Vanderhoek","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MNM.0000000000000974","article-title":"Prognostic value of 18F-FDG PET\/CT functional parameters in patients with head and neck cancer: A meta-analysis","volume":"40","author":"Wang","year":"2019","journal-title":"Nucl. Med. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ejrad.2015.02.030","article-title":"18F-FDG-PET\/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?","volume":"84","author":"Kendi","year":"2015","journal-title":"Eur. J. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40644-016-0095-z","article-title":"Utility of SUV(max) on (18) F-FDG PET in detecting cervical nodal metastases","volume":"16","author":"Lim","year":"2016","journal-title":"Cancer Imaging"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hed.24100","article-title":"AHNS Series\u2014Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors","volume":"38","author":"Roman","year":"2016","journal-title":"Head Neck"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/lary.20201","article-title":"Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy","volume":"119","author":"Rabalais","year":"2009","journal-title":"Laryngoscope"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cncr.27892","article-title":"Impact of positron emission tomography\/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence","volume":"119","author":"Ho","year":"2013","journal-title":"Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-4486.2008.01688.x","article-title":"A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy","volume":"33","author":"Isles","year":"2008","journal-title":"Clin. Otolaryngol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/cncr.20536","article-title":"Value of routine follow-up for patients cured of laryngeal carcinoma","volume":"101","author":"Ritoe","year":"2004","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/hed.10314","article-title":"Postradiotherapy surveillance practice for head and neck squamous cell carcinoma\u2014too much for too little?","volume":"25","author":"Schwartz","year":"2003","journal-title":"Head Neck"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.6004\/jnccn.2015.0010","article-title":"Guideline familiarity predicts variation in self-reported use of routine surveillance PET\/CT by physicians who treat head and neck cancer","volume":"13","author":"Roman","year":"2015","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/lary.23941","article-title":"PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient","volume":"123","author":"Dunsky","year":"2013","journal-title":"Laryngoscope"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/lary.23341","article-title":"Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography\/computed tomography monitoring","volume":"122","author":"Beswick","year":"2012","journal-title":"Laryngoscope"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/lary.23264","article-title":"Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy?","volume":"122","author":"Spector","year":"2012","journal-title":"Laryngoscope"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/s41598-019-39206-1","article-title":"Deep learning in head & neck cancer outcome prediction","volume":"9","author":"Diamant","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14036","DOI":"10.1038\/s41598-018-32441-y","article-title":"Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks","volume":"8","author":"Kann","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.19.02031","article-title":"Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma","volume":"38","author":"Kann","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.sult.2022.02.003","article-title":"Radiomics: A Primer on Processing Workflow and Analysis","volume":"43","author":"Avery","year":"2022","journal-title":"Semin. Ultrasound. CT MR"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s00259-020-04839-2","article-title":"PET\/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinoma","volume":"47","author":"Haider","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/0284186X.2017.1346382","article-title":"Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma","volume":"56","author":"Bogowicz","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14593","DOI":"10.18632\/aging.103508","article-title":"Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment (18)F-PET\/CT","volume":"12","author":"Liu","year":"2020","journal-title":"Aging"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmp.2018.05.013","article-title":"Quantifying the robustness of [(18)F] FDG-PET\/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients","volume":"49","author":"Belli","year":"2018","journal-title":"Phys. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102336","DOI":"10.1016\/j.media.2021.102336","article-title":"Head and neck tumor segmentation in PET\/CT: The HECKTOR challenge","volume":"77","author":"Oreiller","year":"2022","journal-title":"Med. Image Anal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8923028","DOI":"10.1155\/2018\/8923028","article-title":"Fully Automated Delineation of Gross Tumor Volume for Head and Neck Cancer on PET-CT Using Deep Learning: A Dual-Center Study","volume":"2018","author":"Huang","year":"2018","journal-title":"Contrast. Media Mol. Imaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1007\/s00259-020-05125-x","article-title":"Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET\/CT images of head and neck cancer patients","volume":"48","author":"Moe","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_59","first-page":"300","article-title":"Combining Tumor Segmentation Masks with PET\/CT Images and Clinical Data in a Deep Learning Framework for Improved Prognostic Prediction in Head and Neck Squamous Cell Carcinoma","volume":"13209","author":"Wahid","year":"2022","journal-title":"Head Neck Tumor Segm. Chall."},{"key":"ref_60","first-page":"287","article-title":"Progression Free Survival Prediction for Head and Neck Cancer Using Deep Learning Based on Clinical and PET\/CT Imaging Data","volume":"13209","author":"Naser","year":"2022","journal-title":"Head Neck Tumor Segm. Chall."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ypsilantis, P.P., Siddique, M., Sohn, H.M., Davies, A., Cook, G., Goh, V., and Montana, G. (2015). Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137036"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1007\/s00259-020-04859-y","article-title":"Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers","volume":"47","author":"Syed","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Li, Z., Belitzky, E., Blaha, O., Cavaliere, A., Katz, S.R., Aboian, M., Melegari, L., Rajabimoghadam, K., Kurpiewski, S., and Zhu, X. (2023). ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer. Cancers, 15.","DOI":"10.3390\/cancers15051589"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/9\/2651\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:31:03Z","timestamp":1760124663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/9\/2651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":63,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["cancers15092651"],"URL":"https:\/\/doi.org\/10.3390\/cancers15092651","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]}}}